Lindbrook Capital, LLC Vericel Corp Transaction History
Lindbrook Capital, LLC
- $1.18 Billion
- Q3 2024
A detailed history of Lindbrook Capital, LLC transactions in Vericel Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 27 shares of VCEL stock, worth $1,530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 38
28.95%
Holding current value
$1,530
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VCEL
# of Institutions
277Shares Held
48.8MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$457 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$217 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$198 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$138 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$134 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.67B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...